These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 38242634)

  • 1. Neurodevelopmental and synaptic defects in DNAJC6 parkinsonism, amenable to gene therapy.
    Abela L; Gianfrancesco L; Tagliatti E; Rossignoli G; Barwick K; Zourray C; Reid KM; Budinger D; Ng J; Counsell J; Simpson A; Pearson TS; Edvardson S; Elpeleg O; Brodsky FM; Lignani G; Barral S; Kurian MA
    Brain; 2024 Jun; 147(6):2023-2037. PubMed ID: 38242634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNAJC6 Mutations Disrupt Dopamine Homeostasis in Juvenile Parkinsonism-Dystonia.
    Ng J; Cortès-Saladelafont E; Abela L; Termsarasab P; Mankad K; Sudhakar S; Gorman KM; Heales SJR; Pope S; Biassoni L; Csányi B; Cain J; Rakshi K; Coutts H; Jayawant S; Jefferson R; Hughes D; García-Cazorla À; Grozeva D; Raymond FL; Pérez-Dueñas B; De Goede C; Pearson TS; Meyer E; Kurian MA
    Mov Disord; 2020 Aug; 35(8):1357-1368. PubMed ID: 32472658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A deleterious mutation in DNAJC6 encoding the neuronal-specific clathrin-uncoating co-chaperone auxilin, is associated with juvenile parkinsonism.
    Edvardson S; Cinnamon Y; Ta-Shma A; Shaag A; Yim YI; Zenvirt S; Jalas C; Lesage S; Brice A; Taraboulos A; Kaestner KH; Greene LE; Elpeleg O
    PLoS One; 2012; 7(5):e36458. PubMed ID: 22563501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNAJC6 Mutations Associated With Early-Onset Parkinson's Disease.
    Olgiati S; Quadri M; Fang M; Rood JP; Saute JA; Chien HF; Bouwkamp CG; Graafland J; Minneboo M; Breedveld GJ; Zhang J; ; Verheijen FW; Boon AJ; Kievit AJ; Jardim LB; Mandemakers W; Barbosa ER; Rieder CR; Leenders KL; Wang J; Bonifati V
    Ann Neurol; 2016 Feb; 79(2):244-56. PubMed ID: 26528954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LRRK2 phosphorylation of auxilin mediates synaptic defects in dopaminergic neurons from patients with Parkinson's disease.
    Nguyen M; Krainc D
    Proc Natl Acad Sci U S A; 2018 May; 115(21):5576-5581. PubMed ID: 29735704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurodevelopmental defects and neurodegenerative phenotypes in human brain organoids carrying Parkinson's disease-linked
    Wulansari N; Darsono WHW; Woo HJ; Chang MY; Kim J; Bae EJ; Sun W; Lee JH; Cho IJ; Shin H; Lee SJ; Lee SH
    Sci Adv; 2021 Feb; 7(8):. PubMed ID: 33597231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNAJC6 is responsible for juvenile parkinsonism with phenotypic variability.
    Köroğlu Ç; Baysal L; Cetinkaya M; Karasoy H; Tolun A
    Parkinsonism Relat Disord; 2013 Mar; 19(3):320-4. PubMed ID: 23211418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine transporter and synaptic vesicle sorting defects underlie auxilin-associated Parkinson's disease.
    Vidyadhara DJ; Somayaji M; Wade N; Yücel B; Zhao H; Shashaank N; Ribaudo J; Gupta J; Lam TT; Sames D; Greene LE; Sulzer DL; Chandra SS
    Cell Rep; 2023 Mar; 42(3):112231. PubMed ID: 36920906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNAJC6 mutation causing cranial-onset dystonia with tremor dominant levodopa non-responsive parkinsonism: A novel phenotype.
    Ray S; Padmanabha H; Mahale R; Mailankody P; Arunachal G
    Parkinsonism Relat Disord; 2021 Aug; 89():1-3. PubMed ID: 34175496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel Nonsense Mutation in DNAJC6 Expands the Phenotype of Autosomal-Recessive Juvenile-Onset Parkinson's Disease.
    Elsayed LE; Drouet V; Usenko T; Mohammed IN; Hamed AA; Elseed MA; Salih MA; Koko ME; Mohamed AY; Siddig RA; Elbashir MI; Ibrahim ME; Durr A; Stevanin G; Lesage S; Ahmed AE; Brice A
    Ann Neurol; 2016 Feb; 79(2):335-7. PubMed ID: 26703368
    [No Abstract]   [Full Text] [Related]  

  • 11. DNAJC proteins and pathways to parkinsonism.
    Roosen DA; Blauwendraat C; Cookson MR; Lewis PA
    FEBS J; 2019 Aug; 286(16):3080-3094. PubMed ID: 31120186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene therapy restores dopamine transporter expression and ameliorates pathology in iPSC and mouse models of infantile parkinsonism.
    Ng J; Barral S; De La Fuente Barrigon C; Lignani G; Erdem FA; Wallings R; Privolizzi R; Rossignoli G; Alrashidi H; Heasman S; Meyer E; Ngoh A; Pope S; Karda R; Perocheau D; Baruteau J; Suff N; Antinao Diaz J; Schorge S; Vowles J; Marshall LR; Cowley SA; Sucic S; Freissmuth M; Counsell JR; Wade-Martins R; Heales SJR; Rahim AA; Bencze M; Waddington SN; Kurian MA
    Sci Transl Med; 2021 May; 13(594):. PubMed ID: 34011628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of Protease Cathepsin D and Upregulation of Pathologic α-Synuclein Mediate Paucity of DNAJC6-Induced Degeneration of Dopaminergic Neurons.
    Chiu CC; Chen YL; Weng YH; Liu SY; Li HL; Yeh TH; Wang HL
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parkinsonism mutations in DNAJC6 cause lipid defects and neurodegeneration that are rescued by Synj1.
    Jacquemyn J; Kuenen S; Swerts J; Pavie B; Vijayan V; Kilic A; Chabot D; Wang YC; Schoovaerts N; Corthout N; Verstreken P
    NPJ Parkinsons Dis; 2023 Feb; 9(1):19. PubMed ID: 36739293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation in the SYNJ1 gene associated with autosomal recessive, early-onset Parkinsonism.
    Quadri M; Fang M; Picillo M; Olgiati S; Breedveld GJ; Graafland J; Wu B; Xu F; Erro R; Amboni M; Pappatà S; Quarantelli M; Annesi G; Quattrone A; Chien HF; Barbosa ER; ; Oostra BA; Barone P; Wang J; Bonifati V
    Hum Mutat; 2013 Sep; 34(9):1208-15. PubMed ID: 23804577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Co-chaperones in Synaptic Proteostasis and Neurodegenerative Disease.
    Gorenberg EL; Chandra SS
    Front Neurosci; 2017; 11():248. PubMed ID: 28579939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parkinson Sac Domain Mutation in Synaptojanin 1 Impairs Clathrin Uncoating at Synapses and Triggers Dystrophic Changes in Dopaminergic Axons.
    Cao M; Wu Y; Ashrafi G; McCartney AJ; Wheeler H; Bushong EA; Boassa D; Ellisman MH; Ryan TA; De Camilli P
    Neuron; 2017 Feb; 93(4):882-896.e5. PubMed ID: 28231468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A New Glucocerebrosidase Chaperone Reduces α-Synuclein and Glycolipid Levels in iPSC-Derived Dopaminergic Neurons from Patients with Gaucher Disease and Parkinsonism.
    Aflaki E; Borger DK; Moaven N; Stubblefield BK; Rogers SA; Patnaik S; Schoenen FJ; Westbroek W; Zheng W; Sullivan P; Fujiwara H; Sidhu R; Khaliq ZM; Lopez GJ; Goldstein DS; Ory DS; Marugan J; Sidransky E
    J Neurosci; 2016 Jul; 36(28):7441-52. PubMed ID: 27413154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Derivation of induced pluripotent stem cell SHEHDNi002-A from a 68-year-old Chinese Han Parkinson's disease patient carrying LRRK2 and DNAJC6 mutations.
    Liu H; Zhao Z; Zhao J; Xu L; Li J; Zhang B
    Stem Cell Res; 2024 Mar; 75():103297. PubMed ID: 38219303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocytosis and clathrin-uncoating defects at synapses of auxilin knockout mice.
    Yim YI; Sun T; Wu LG; Raimondi A; De Camilli P; Eisenberg E; Greene LE
    Proc Natl Acad Sci U S A; 2010 Mar; 107(9):4412-7. PubMed ID: 20160091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.